Don't want ads? Subscribe or login now.

Appeal 'Overlap' Preserves Akebia Kidney Drug Coverage Suit

By Kevin Stawicki · September 24, 2020, 10:54 PM EDT

A Massachusetts federal judge on Thursday rejected the federal government's bid to toss Akebia Therapeutics Inc.'s suit challenging the Centers for Medicare & Medicaid Services' exclusion of its kidney disease drug...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

Akebia Therapeutics, Inc. v. Azar et al

Case Number

1:19-cv-12132

Court

Massachusetts

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

October 15, 2019

Recent Articles By Kevin

November 20, 2020
Trump Slams Big Pharma In Rollout Of Drug Price Rules
November 17, 2020
House Passes Bill Targeting Orphan Drug Exclusivity
November 16, 2020
Calif. Used Virus To Upend Health Plan Contracts, Suit Says
October 29, 2020
Aetna To Pay HHS $1M For Exposing Customer HIV Info
October 22, 2020
Blue Shield Can't Revive $12M Patient Shifting Payment Suit
October 16, 2020
CVS, Walgreens Tapped To Dispense COVID-19 Vaccine
October 16, 2020
5th Circ. Revives Devout Catholic's ACA Challenge
October 06, 2020
Justices Urged To Undo Trump's Abortion Referral 'Gag Rule'
September 24, 2020
Insurers Lose ACA Health Exchange Tax Challenge In DC
September 23, 2020
Veteran Mental Health Bill Sent To Trump, Other Bills Proceed